Is more clarity needed in the HSE's drugs group decision making?
21 August - 8 mins
Podcast Series
The Hard Shoulder
The HSE drugs group’s recommendation to refuse reimbursement for the drug Skyclarys is a stark reminder of the devastating human cost that can lie behind bureaucratic decisions. So wrote Consultant in Paediatric Intensive Care, Dr Suzanne Crowe, in The Journal yesterday.
She joins Ciara to discuss.
Series Episodes
